Načítá se...
A serum-stable branched dimeric anti-VEGF peptide blocks tumor growth via anti-angiogenic activity
Angiogenesis is critical and indispensable for tumor progression. Since VEGF is known to play a central role in angiogenesis, the disruption of VEGF-VEGF receptor system is a promising target for anti-cancer therapy. Previously, we reported that a hexapeptide (RRKRRR, RK6) blocked the growth and met...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Korean Society for Biochemistry and Molecular Biology
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2912478/ https://ncbi.nlm.nih.gov/pubmed/20543548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3858/emm.2010.42.7.052 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|